Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.
BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
New insights into the structure of muscle tissue in the heart have been provided in a study led by researchers from McGill University. This is a finding that promises to contribute to the study of ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. The heart is the central organ of the human circulatory system. Both congenital and acquired structural ...
BAG3 DCM is a devastating monogenic heart disease affecting more than 70,000 patients in the U.S., Europe, and U.K., with almost 25% of patients requiring a heart transplant AFTX-201 is a potential ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results